Cargando…

Photobiomodulation Suppresses Alpha-Synuclein-Induced Toxicity in an AAV-Based Rat Genetic Model of Parkinson’s Disease

Converging lines of evidence indicate that near-infrared light treatment, also known as photobiomodulation (PBM), may exert beneficial effects and protect against cellular toxicity and degeneration in several animal models of human pathologies, including neurodegenerative disorders. In the present s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oueslati, Abid, Lovisa, Blaise, Perrin, John, Wagnières, Georges, van den Bergh, Hubert, Tardy, Yanik, Lashuel, Hilal A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617694/ https://www.ncbi.nlm.nih.gov/pubmed/26484876 http://dx.doi.org/10.1371/journal.pone.0140880

Ejemplares similares

Near-Infrared 808 nm Light Boosts Complex IV-Dependent Respiration and Rescues a Parkinson-Related pink1 Model
por: Vos, Melissa, et al.
Publicado: (2013)

Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies
por: Magalhães, Pedro, et al.
Publicado: (2022)

Alpha-Synuclein and the Endolysosomal System in Parkinson’s Disease: Guilty by Association
por: Teixeira, Maxime, et al.
Publicado: (2021)

The mechanism of sirtuin 2–mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease
por: de Oliveira, Rita Machado, et al.
Publicado: (2017)

Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?
por: Oueslati, Abid
Publicado: (2016)

Correction: The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease
por: de Oliveira, Rita Machado, et al.
Publicado: (2017)

Administration of AAV-Alpha Synuclein NAC Antibody Improves Locomotor Behavior in Rats Overexpressing Alpha Synuclein
por: Chen, Yun-Hsiang, et al.
Publicado: (2021)

Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains
por: Bérard, Morgan, et al.
Publicado: (2023)

Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
por: Oliveira, Luis M. A., et al.
Publicado: (2021)

Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein
por: Dening, Yanina, et al.
Publicado: (2022)

Effect of Photobiomodulation on Protein Kinase Cδ, Cytochrome C, and Mitochondria in U87 MG Cells
por: Pevná, Viktória, et al.
Publicado: (2023)

The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
por: Kelly, Rachel, et al.
Publicado: (2021)

Autophagy and Apoptosis Induced in U87 MG Glioblastoma Cells by Hypericin-Mediated Photodynamic Therapy Can Be Photobiomodulated with 808 nm Light
por: Pevna, Viktoria, et al.
Publicado: (2021)

Loss of Functional Alpha-Synuclein: A Toxic Event in Parkinson’s Disease?
por: Kanaan, Nicholas M., et al.
Publicado: (2012)

Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
por: García-Revilla, Juan, et al.
Publicado: (2023)

Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in rats
por: Gubinelli, F., et al.
Publicado: (2022)

Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson’s Disease and Multiple System Atrophy
por: Sonustun, Berkiye, et al.
Publicado: (2022)

Overexpression of human alpha-Synuclein leads to dysregulated microbiome/metabolites with ageing in a rat model of Parkinson disease
por: Singh, Yogesh, et al.
Publicado: (2023)

Neonatal AAV delivery of alpha-synuclein induces pathology in the adult mouse brain
por: Delenclos, Marion, et al.
Publicado: (2017)

Transmission of alpha-synuclein in Parkinson’s disease
por: Lee, Virginia M-Y
Publicado: (2013)

Alpha-synuclein spreading in Parkinson’s disease
por: Recasens, Ariadna, et al.
Publicado: (2014)

Alpha-Synuclein Aggregation in Parkinson's Disease
por: Srinivasan, E., et al.
Publicado: (2021)

Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders
por: Altay, Melek Firat, et al.
Publicado: (2022)

Parkinson-related parkin reduces α-Synuclein phosphorylation in a gene transfer model
por: Khandelwal, Preeti J, et al.
Publicado: (2010)

Alpha-synuclein Toxicity in the Early Secretory Pathway: How It Drives Neurodegeneration in Parkinsons Disease
por: Wang, Ting, et al.
Publicado: (2015)

Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
por: Gómez-Benito, Mónica, et al.
Publicado: (2020)

Alpha-Synuclein and Cognitive Decline in Parkinson Disease
por: Fan, Tian-Sin, et al.
Publicado: (2021)

Monitoring alpha‐synuclein oligomerization and aggregation using bimolecular fluorescence complementation assays: What you see is not always what you get
por: Frey, Bryan, et al.
Publicado: (2020)

Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson’s Disease
por: Brembati, Viviana, et al.
Publicado: (2023)

Comparative Analysis of Total Alpha-Synuclein (αSYN) Immunoassays Reveals That They Do Not Capture the Diversity of Modified αSYN Proteoforms
por: Petricca, Lara, et al.
Publicado: (2022)

Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensity
por: Stephens, Amberley D., et al.
Publicado: (2020)

Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization
por: Lurette, Olivier, et al.
Publicado: (2023)

Rationale for Therapeutic Silencing of Alpha-Synuclein in Parkinson’s Disease
por: Maraganore, Demetrius M.
Publicado: (2011)

Interaction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease
por: Xu, Shengli, et al.
Publicado: (2015)

Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation
por: George, Sonia, et al.
Publicado: (2015)

New Perspectives on Roles of Alpha-Synuclein in Parkinson’s Disease
por: Zhang, Guoxin, et al.
Publicado: (2018)

The Identification of Alpha-Synuclein as the First Parkinson Disease Gene
por: Nussbaum, Robert L.
Publicado: (2017)

Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson’s Disease
por: Fitzgerald, Emily, et al.
Publicado: (2019)

Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
por: Fields, Carroll Rutherford, et al.
Publicado: (2019)

Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease
por: Li, Puyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2t31baeihov8l8eink2775lfgc